seizures

colorful brain art model

Biotech

Praxis pauses one of its seizure programs after phase 2 fail

Praxis Precision Medicines’ epilepsy pipeline suffered a setback after a NaV blocker failed to sufficiently reduce seizures in a phase 2/3 study.

James Waldron Jun 2, 2026 5:23am

home run

Xenon epilepsy candidate 'blows away' ph. 3 expectations

Mar 9, 2026 10:55am

Lightbulb with an image of a brain inside

Bright Minds anti-seizure candidate shines in phase 2 win

Jan 6, 2026 10:38am

colorful brain art model

Praxis sees success in ph. 2 seizure trial, setting up FDA push

Dec 5, 2025 10:00am

A baby inside of an incubator

Ceribell nets FDA nod for detecting seizures in preterm newborns

Nov 26, 2025 9:49am

rocket ship blast off fire away take off

Rapport's seizure drug hits in phase 2, sending stock soaring

Sep 8, 2025 8:25am